We have reported previously that the nitric oxide (NO) donor FK409 {(±)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexanamide} improved renal dysfunction as well as renal lesions in rats with ischaemia/reperfusion injury. We also found that FK409 substantially reduced endothelin-1 (ET-1) production in cultured vascular endothelial cells (ECs). Nuclear factor κB (NF-κB) is known to play a key role in the development of ischaemic disorders through regulation of the expression of a variety of genes. In the present study, we examined the effects of FK409 on ET-1 production in cultured pig aortic ECs, and the possible involvement of NF-κB in the inhibitory effect of NO on ET-1 production. FK409 significantly attenuated basal and tumour necrosis factor-α (TNF-α)-induced preproET-1 mRNA expression in ECs. In addition, FK409 diminished basal and TNF-α-stimulated NF-κB activation in ECs. Pretreatment with N-benzyloxycarbonyl-Ile-Glu(O-t-Bu)-Ala-leucinal or BAY 11-7082, both of which are suppressors of NF-κB activation, effectively attenuated basal and TNF-α-induced ET-1 mRNA expression. These findings suggest that the suppression of NF-κB activation is at least partly involved in the FK409-induced inhibition of ET-1 production in ECs. We propose that NF-κB activation plays an important role in ET-1 production.
Skip Nav Destination
Close
Article navigation
September 2002
Conference Article|
September 01 2002
Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor κB
Mamoru OHKITA
;
Mamoru OHKITA
1Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
Search for other works by this author on:
Masanori TAKAOKA
;
Masanori TAKAOKA
1Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
Search for other works by this author on:
Yasuko SHIOTA
;
Yasuko SHIOTA
1Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
Search for other works by this author on:
Rumi NOJIRI
;
Rumi NOJIRI
1Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
Search for other works by this author on:
Yasuo MATSUMURA
1Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
Dr Yasuo Matsumura (e-mail matumrh@gly.oups.ac.jp).
Search for other works by this author on:
Clin Sci (Lond) (2002) 103 (s2002): 68S–71S.
Citation
Mamoru OHKITA, Masanori TAKAOKA, Yasuko SHIOTA, Rumi NOJIRI, Yasuo MATSUMURA; Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor κB. Clin Sci (Lond) 1 September 2002; 103 (s2002): 68S–71S. doi: https://doi.org/10.1042/CS103S068S
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Related Articles
The immunosuppressive drug mycophenolic acid reduces endothelin-1 synthesis in endothelial cells and renal epithelial cells
Clin Sci (Lond) (September,2002)
Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species
Clin Sci (Lond) (September,2002)
Effect of endothelin-1 on endothelium-derived vascular responsiveness in man
Clin Sci (Lond) (August,1998)
l-Arginine Increases Exhaled Nitric Oxide in Normal Human Subjects
Clin Sci (Lond) (February,1995)